Clinical Trials in France / NCT06968741
Active, not recruiting
Not applicable
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
NCT06968741 · tracked via the Priya Life Science France tracker
Condition(s) studied
Stress Urinary Incontinence (SUI)
Investigational drug(s) / intervention(s)
Artificial Urinary Sphincter (AUS)
Artificial Urinary Sphincter (AUS): AUS implant
Study summary
Prospective, multicenter, single-arm study
Eligibility
Key Inclusion Criteria:
* Male subjects aged ≥ 22 years old
* Able to read, comprehend and willing to sign an informed consent form
* Primary diagnosis of stress urinary incontinence for at least 6 months, as assessed by the investigator
* Appropriate surgical candidate with no medical or mental condition that would interfere with study procedures or confound study outcomes as assessed by the investigator
Key Exclusion Criteria:
* Currently enrolled or plans to enroll in another investigational device or clinical drug trial or has completed an investigational study (for urinary incontinence) in the past 3 months prior to informed consent
* Poor candidate for surgical procedures and/or anesthesia, as determined by investigator
* Currently implanted with an Active Implantable Medical Device (AIMD)
* Symptoms or diagnosis of urge incontinence or mixed incontinence (MI) with a predominant urgency component, as assessed by the investigator
Primary outcome measure(s)
- Responder rate at 26 weeks post-activation — 26 weeks
Proportion of subjects who report greater than or equal to 50% reduction in the 24 hour Pad Weight Test (PWT) at 26 weeks compared with Baseline
Trial sites (21)
| Facility | City | Region | Status |
|---|---|---|---|
| University of California, Los Angeles | Los Angeles | California | |
| University of California, San Francisco | San Francisco | California | |
| Stanford University | Stanford | California | |
| Minnesota Urology | Bloomington | Minnesota | |
| Mayo Clinic | Rochester | Minnesota | |
| Wake Forest University of Health Sciences | Charlotte | North Carolina | |
| Duke University | Durham | North Carolina | |
| Cleveland Clinic Foundation | Cleveland | Ohio | |
| Vanderbilt University Medical Center | Nashville | Tennessee | |
| Urology Clinics of North Texas | Dallas | Texas | |
| University of Texas, Southwestern | Dallas | Texas | |
| University of Texas, MD Anderson | Houston | Texas | |
| Urology of Virginia | Virginia Beach | Virginia | |
| Centre Hospitalier Universitaire de Lille | Lille | France | |
| Hospitals Academics De Marseille Conception | Marseille | France | |
| Centre Hospitalier Universitaire de Nantes | Nantes | France | |
| Groupe Hospitalier Pitié-Salpêtrière | Paris | France | |
| Centre Hospitalier Univeritaire de Lyon - Hôpital Lyon Sud | Pierre-Bénite | France | |
| Centre Hospitalier Universitaire de Rennes | Rennes | France | |
| Centre Hospitalier Universitaire de Rouen | Rouen | France | |
| Hopital Foch | Suresnes | France |
More UroMems SAS trials in France
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06968741 on ClinicalTrials.gov ↗ ← All trials in France